The tool aims to facilitate timely preventive measures and treatments. Credit: Cambridge Memorial Hospital.

Cambridge Memorial Hospital in Ontario, Canada, has partnered with 16 Bit to implement an artificial intelligence (AI)-powered tool called Rho.

The hospital is said to be the first in Ontario to adopt the solution for clinical use.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

This Health Canada-approved system leverages AI to analyse routine X-rays in patients aged 50 and above for low BMD.

When low BMD is detected, the tool flags the X-ray for further review, aiding radiologists in identifying this condition earlier.

This early detection is aimed at facilitating timely preventive measures and treatments.

Rho aims to address the prevalence of low BMD, including osteopenia and osteoporosis, by identifying patients who may benefit from more specialised tests for bone density during routine X-ray exams. It can analyse 80% of all X-rays conducted.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The solution is said to be gaining popularity among independent healthcare facilities across Canada.

Rho has screened over 50,000 patients within its first year on the market, with a target of screening one million patients by the end of 2024.

Cambridge Memorial Hospital diagnostic imaging chief Dr Winnie Lee said: “Rho is a tool that will bring care closer to home and makes this advanced technology accessible to people in Cambridge, North Dumfries, and the Region of Waterloo.

“Good bone health contributes to overall quality of life. By acting early, we can help patients at risk of osteopenia lead full lives and avoid some of the fractures that might bring them to the hospital.”